glp 1 drugs and gallstones A monthly GLP-1 dose could cut the number of shots patients take each year from 52 to 12. Side effects from the drug — mainly gastrointestinal symptoms — were similar to or Why GLP-1 Agonists Like Ozempic

Eli Lilly has built a $1.5 billion inventory of orforglipron ahead of the anticipated FDA decision, signaling confidence in approval and readiness for commercial launch

Children who made comments to parents about their own weight were more likely to notice parents weight loss

Intern Emerg Med [Internet]

10.1016/j.isci.2023.107680 [DOI] [PMC free article] [PubMed] [Google Scholar] Wei L., Mo W., Lan S., Yang H., Huang Z., Liang X., et al

We have seen first-hand at our Connecticut practice how new GLP-1 drugs like semaglutide (Ozempic/Wegovy) and Tirzepatide (Mounjaro/Zepbound) have fundamentally transformed how we treat obesity and chronic metabolic disease